105 related articles for article (PubMed ID: 22660807)
1. Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis.
Rodríguez-Lozano C; Gantes MÁ; González B; Hernández-Beriain JA; Naranjo A; Hernández V; Quevedo-Abeledo JC; Falcón MJ; Machín S; Descalzo MA
J Rheumatol; 2012 Jul; 39(7):1424-32. PubMed ID: 22660807
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.
Maksymowych WP; Richardson R; Mallon C; van der Heijde D; Boonen A
Arthritis Rheum; 2007 Feb; 57(1):133-9. PubMed ID: 17266072
[TBL] [Abstract][Full Text] [Related]
3. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.
Tubach F; Pham T; Skomsvoll JF; Mikkelsen K; Bjørneboe O; Ravaud P; Dougados M; Kvien TK
Arthritis Rheum; 2006 Dec; 55(6):960-3. PubMed ID: 17139643
[TBL] [Abstract][Full Text] [Related]
4. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study.
Tubach F; Ravaud P; Martin-Mola E; Awada H; Bellamy N; Bombardier C; Felson DT; Hajjaj-Hassouni N; Hochberg M; Logeart I; Matucci-Cerinic M; van de Laar M; van der Heijde D; Dougados M
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1699-707. PubMed ID: 22674853
[TBL] [Abstract][Full Text] [Related]
5. Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics.
Maksymowych WP; Gooch K; Dougados M; Wong RL; Chen N; Kupper H; van der Heijde D
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):826-34. PubMed ID: 20535793
[TBL] [Abstract][Full Text] [Related]
6. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001
[TBL] [Abstract][Full Text] [Related]
7. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Kvamme MK; Kristiansen IS; Lie E; Kvien TK
J Rheumatol; 2010 Jan; 37(1):26-31. PubMed ID: 19955045
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
Sellas I Fernandez A; Juanola Roura X; Alonso Ruiz A; Rosas J; Medina Luezas J; Collantes Estevez E; Abad Hernández MÁ; Carrasco Benitez V; Fisac C
Rheumatol Int; 2017 Nov; 37(11):1817-1823. PubMed ID: 28918450
[TBL] [Abstract][Full Text] [Related]
10. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
[TBL] [Abstract][Full Text] [Related]
11. The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis.
Kviatkovsky MJ; Ramiro S; Landewé R; Dougados M; Tubach F; Bellamy N; Hochberg M; Ravaud P; Martin-Mola E; Awada H; Bombardier C; Felson D; Hajjaj-Hassouni N; Logeart I; Matucci-Cerinic M; van de Laar M; van der Heijde D
J Rheumatol; 2016 Sep; 43(9):1680-6. PubMed ID: 27307522
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.
Dougados M; Luo MP; Maksymowych WP; Chmiel JJ; Chen N; Wong RL; Davis JC; van der Heijde D;
Arthritis Rheum; 2008 Apr; 59(4):553-60. PubMed ID: 18383418
[TBL] [Abstract][Full Text] [Related]
13. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
14. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.
Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Kalstad S; Kvien TK
Rheumatology (Oxford); 2012 Aug; 51(8):1479-83. PubMed ID: 22499062
[TBL] [Abstract][Full Text] [Related]
15. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
16. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
DU XN; Li Y; Zhang SL; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
[TBL] [Abstract][Full Text] [Related]
18. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures.
Dagfinrud H; Vollestad NK; Loge JH; Kvien TK; Mengshoel AM
Arthritis Rheum; 2005 Feb; 53(1):5-11. PubMed ID: 15696569
[TBL] [Abstract][Full Text] [Related]
19. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study.
Pavy S; Brophy S; Calin A
J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730
[TBL] [Abstract][Full Text] [Related]
20. Parent and child acceptable symptom state in juvenile idiopathic arthritis.
Filocamo G; Consolaro A; Schiappapietra B; Ruperto N; Pistorio A; Solari N; Pederzoli S; Verazza S; Martini A; Ravelli A
J Rheumatol; 2012 Apr; 39(4):856-63. PubMed ID: 22298905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]